Silymarin Cyclodextrin Complexes for Solubility and Bioavailability

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Silymarin, a flavonolignan derived from Silybum marianum, has low solubility and bioavailability due to its poor water solubility and lack of lipophilic properties, limiting its effectiveness in cosmetic and dietary supplement applications.

Innovation Solution

Forming inclusion complexes of silymarin with sulfoalkyl ether cyclodextrin to enhance solubility and bioavailability, thereby improving the efficacy of silymarin-based compositions for topical application and dietary supplements.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If silymarin is used in its native form, then it provides hepatoprotective and antioxidant effects, but its low water solubility and poor bioavailability limit its effectiveness

Engineering Contradiction:

ImproveeffectivenessVSAvoidsolubility

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The patent uses cyclodextrin as an intermediary substance to form inclusion complexes with silymarin. The cyclodextrin molecule has a hydrophilic exterior and a hydrophobic cavity, allowing it to encapsulate the hydrophobic silymarin molecules and present a water-soluble exterior to the aqueous environment, thereby resolving the solubility contradiction

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite material system consisting of cyclodextrin-silymarin inclusion complexes. This composite combines the water-soluble properties of cyclodextrin with the bioactive properties of silymarin, achieving both improved solubility and maintained effectiveness

Inventive Principle:

Principle #40Composite materials

2Reliability

If silymarin is used in its native form, then it provides biological activities, but its lack of lipophilic properties prevents effective membrane permeation

Engineering Contradiction:

Improvebiological activityVSAvoidmembrane permeation

Core Design Contradiction:

ReliabilityVSEase of operation

Solution Approach 1:

Cyclodextrin acts as a mediator that facilitates membrane permeation. The inclusion complex structure allows silymarin to be delivered across biological membranes more effectively, with the cyclodextrin portion aiding in transport while the silymarin maintains its biological activity upon release

Inventive Principle:

Principle #24Intermediary (Mediator)

3Quantity of substance

If silymarin is administered at higher doses to overcome low bioavailability, then more active ingredient is provided, but the formulation complexity and manufacturing difficulty increase

Engineering Contradiction:

ImprovebioavailabilityVSAvoidformulation complexity

Core Design Contradiction:

Quantity of substanceVSEase of manufacture

Solution Approach 1:

The invention changes the physical-chemical parameters of silymarin by forming inclusion complexes. This parameter change (from pure silymarin to complexed silymarin) improves bioavailability without requiring complex formulation strategies or high processing temperatures that would increase manufacturing difficulty

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solubility and bioavailability of silymarin are significantly enhanced, enabling effective methods for reducing skin aging, rejuvenating skin, and treating skin conditions, as well as providing liver protection.

Implementation Method 1

Forming inclusion complexes of silymarin with sulfoalkyl ether cyclodextrin to enhance solubility and bioavailability

Methodology Applied

Scientific EffectInclusion complex formation: Absorption (physical)

Data Source

PatentUS20260091073A1Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same

Publication Date: 2026.04.02 CYDEX PHARMACEUTICALS INC

AI summary

Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.